Introducing the ASTUTE trial, sponsored by @uhbwNHS - a randomised controlled trial looking at #adalimumab for the treatment of #autoimmune#uveitis. The trial is in set up and we look forward to bringing you more news soon! Follow us to stay up to date. @andrewdick4@Abby_OCon
Uveitis CSG guidance on #uveitis patients during #COVID19 pandemic.
Created in partnership with paed+adult rheumatologists, NHSE for a unified cross-disciplinary response.
https://t.co/axx3qmLI12
We've convened the UK’s leading ophthalmologists to draw attention to the ‘1:20 funding gap’ in eye research. A public letter published in today’s Guardian, calls on the new government to develop a national plan on sight loss. Read more here 👉 https://t.co/8PqflGXTwj
Many children with #uveitis can’t tell when things are active - that’s why eye checks in #JIA are so important - but some children & young people CAN feel it. Please help us shine a light on this🕵🏾♀️Thank you @OliviasVision & @JIA_Matters!
Under-utilization of reproducible, child appropriate or patient reported outcome measures in childhood uveitis interventional research, reviewed in OJRD #RareDisease https://t.co/CY2QPzNi49
This weekend ICD-11 has been officially presented to Member States at the 2019 World Health Assembly. I hope the added granularity in the ICD-11 definitions for vision impairment better guides the data we need to impact avoidable vision loss globally https://t.co/tFAr0b92Du
Uncertainty amongst #uveitis specialists on the management of childhood non-infectious chronic anterior uveitis in the UK. This study highlights the need for research to improve outcomes and provide evidence based medicine @lolaeyedoc. https://t.co/Oqqtj7OOet
@EquatorVision An important milestone in moving the care of patients with #uveitis to the modern era. We're aiming to replace traditional clinician guesstimates with measures that are sensitive, objective and reliable. Thanks Gary for your vision and hard work.